218 related articles for article (PubMed ID: 21252514)
1. Membranous nephropathy.
Cybulsky AV
Contrib Nephrol; 2011; 169():107-125. PubMed ID: 21252514
[TBL] [Abstract][Full Text] [Related]
2. Experimental membranous nephropathy redux.
Cybulsky AV; Quigg RJ; Salant DJ
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F660-71. PubMed ID: 16159900
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular biology of membranous nephropathy.
Couser WG; Nangaku M
J Nephrol; 2006; 19(6):699-705. PubMed ID: 17173240
[TBL] [Abstract][Full Text] [Related]
4. Cellular response to injury in membranous nephropathy.
Nangaku M; Shankland SJ; Couser WG
J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
[TBL] [Abstract][Full Text] [Related]
5. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
[TBL] [Abstract][Full Text] [Related]
6. Podocyte antigens and glomerular disease.
Ronco P; Debiec H
Nephron Exp Nephrol; 2007; 107(2):e41-6. PubMed ID: 17726340
[TBL] [Abstract][Full Text] [Related]
7. A podocyte view of membranous nephropathy: from Heymann nephritis to the childhood human disease.
Ronco P; Debiec H
Pflugers Arch; 2017 Aug; 469(7-8):997-1005. PubMed ID: 28597189
[TBL] [Abstract][Full Text] [Related]
8. Complement-mediated cellular injury.
Takano T; Elimam H; Cybulsky AV
Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
[TBL] [Abstract][Full Text] [Related]
9. Contrasting roles of complement activation and its regulation in membranous nephropathy.
Cunningham PN; Quigg RJ
J Am Soc Nephrol; 2005 May; 16(5):1214-22. PubMed ID: 15800113
[TBL] [Abstract][Full Text] [Related]
10. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
Ronco P; Debiec H
Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
[TBL] [Abstract][Full Text] [Related]
11. Immunology of membranous nephropathy: from animal models to humans.
Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
[TBL] [Abstract][Full Text] [Related]
12. Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.
Wang H; Liu H; Cheng H; Xue X; Ge Y; Wang X; Yuan J
Am J Nephrol; 2024; 55(3):345-360. PubMed ID: 38330925
[TBL] [Abstract][Full Text] [Related]
13. Complement mediates nephrin redistribution and actin dissociation in experimental membranous nephropathy.
Saran AM; Yuan H; Takeuchi E; McLaughlin M; Salant DJ
Kidney Int; 2003 Dec; 64(6):2072-8. PubMed ID: 14633129
[TBL] [Abstract][Full Text] [Related]
14. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G; Lorenzen JM; Ma H; de Haan N; Seeger H; Zaghrini C; Brandt S; Kölling M; Wegmann U; Kiss B; Pál G; Gál P; Wüthrich RP; Wuhrer M; Beck LH; Salant DJ; Lambeau G; Kistler AD
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33351779
[TBL] [Abstract][Full Text] [Related]
15. Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy.
Liu WJ; Li ZH; Chen XC; Zhao XL; Zhong Z; Yang C; Wu HL; An N; Li WY; Liu HF
Sci Rep; 2017 Aug; 7(1):8643. PubMed ID: 28819100
[TBL] [Abstract][Full Text] [Related]
16. The role of complement in membranous nephropathy.
Ma H; Sandor DG; Beck LH
Semin Nephrol; 2013 Nov; 33(6):531-42. PubMed ID: 24161038
[TBL] [Abstract][Full Text] [Related]
17. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy.
Gao S; Cui Z; Zhao MH
J Am Soc Nephrol; 2022 Sep; 33(9):1742-1756. PubMed ID: 35777783
[TBL] [Abstract][Full Text] [Related]
18. [Molecular analysis of experimental membranous glomerulonephritis (Heymann nephritis)].
Kerjaschki D
Verh Dtsch Ges Pathol; 1996; 80():139-47. PubMed ID: 9064996
[TBL] [Abstract][Full Text] [Related]
19. Podocytes that detach in experimental membranous nephropathy are viable.
Petermann AT; Krofft R; Blonski M; Hiromura K; Vaughn M; Pichler R; Griffin S; Wada T; Pippin J; Durvasula R; Shankland SJ
Kidney Int; 2003 Oct; 64(4):1222-31. PubMed ID: 12969140
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.
Prunotto M; Carnevali ML; Candiano G; Murtas C; Bruschi M; Corradini E; Trivelli A; Magnasco A; Petretto A; Santucci L; Mattei S; Gatti R; Scolari F; Kador P; Allegri L; Ghiggeri GM
J Am Soc Nephrol; 2010 Mar; 21(3):507-19. PubMed ID: 20150532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
